Results from a new small study suggest people aged 50 and older with MS who want to discontinue disease-modifying therapy can do so with cladribine with minimal risk for relapse.
Significant predictors of 28-day mortality in critically ill patients with systemic sclerosis include male sex and BMI.
New data from ACTRIMS 2026 suggests biological age acceleration in pediatric MS is not reflected in current clinical or cognitive assessments.
In patients experiencing refractory ischemic digital complications from systemic sclerosis or other diseases, BTX injections are safe and effective.
Parkinson's disease does more than cause tremor and trouble walking. It can also affect sleep, smell, digestion and even ...
MASLD/MASH represents a growing clinical and economic burden, with MASH conferring heightened risks of advanced fibrosis, cirrhosis, hepatocellular carcinoma, and liver-related mortality. Noninvasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results